Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (12): 1129-1134.DOI: 10.3969/j.issn.1673-8640.2022.12.006
Previous Articles Next Articles
YANG Xue, JU Yi(), OU Yuanzhu, ZHU Yuqing, XU Chong, JIANG Lingli, WANG Qing, ZHOU Jing
Received:
2021-11-25
Revised:
2022-01-10
Online:
2022-12-30
Published:
2023-02-02
Contact:
JU Yi,E-mail:juyi@sccl.org.cn。
CLC Number:
YANG Xue, JU Yi, OU Yuanzhu, ZHU Yuqing, XU Chong, JIANG Lingli, WANG Qing, ZHOU Jing. Analysis on the results of external quality assessment of mutual recognition quantitative items in Shanghai[J]. Laboratory Medicine, 2022, 37(12): 1129-1134.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.12.006
医疗机构类型 | 实验室数/家 | 百分比/% |
---|---|---|
三级公立医院 | 74 | 9.23 |
二级公立医院 | 116 | 14.46 |
一级公立医院 | 251 | 31.30 |
社会办医院 | 338 | 42.14 |
医学检验实验室 | 23 | 2.87 |
合计 | 802 | 100.00 |
医疗机构类型 | 实验室数/家 | 百分比/% |
---|---|---|
三级公立医院 | 74 | 9.23 |
二级公立医院 | 116 | 14.46 |
一级公立医院 | 251 | 31.30 |
社会办医院 | 338 | 42.14 |
医学检验实验室 | 23 | 2.87 |
合计 | 802 | 100.00 |
项目 | 实验室数/家 | EQA合格率/% | 分组数 | TEaSCCL/ % | σSCCL | TEamax/ % | TEamax 来源 | σmax | TEamin/ % | TEamin 来源 | σmin |
---|---|---|---|---|---|---|---|---|---|---|---|
临床生化类 | |||||||||||
总蛋白 | 461 | 99.57 | 11 | 5.0 | 1.63 | 10.0 | e | 3.98 | 3.5 | c | 0.90 |
白蛋白 | 468 | 99.36 | 2 | 6.0 | 0.95 | 20.0 | e | 4.83 | 3.4 | c | 0.24 |
丙氨酸氨基转移酶 | 472 | 100.00 | 11 | 16.0 | 4.27 | 21.0 | e | 5.84 | 12.0 | d | 3.01 |
天门冬氨酸氨基转移酶 | 461 | 99.78 | 11 | 15.0 | 4.55 | 21.0 | e | 6.68 | 12.0 | d | 3.48 |
γ-谷氨酰转肽酶 | 455 | 99.78 | 11 | 11.0 | 2.94 | 21.0 | e | 6.31 | 11.0 | a | 2.94 |
总胆红素 | 459 | 98.69 | 2 | 15.0 | 2.35 | 22.0 | e | 3.81 | 12.0 | d | 1.72 |
总胆固醇 | 445 | 98.88 | 11 | 9.0 | 3.42 | 13.0 | e | 5.37 | 6.0 | d | 1.96 |
三酰甘油 | 446 | 99.55 | 11 | 14.0 | 2.97 | 27.0 | c | 6.43 | 12.0 | d | 2.43 |
镁 | 160 | 93.75 | 8 | 15.0 | 1.79 | 15.0 | a、b、e | 1.79 | 4.0 | c | -0.10 |
铁 | 115 | 100.00 | 7 | 15.0 | 4.91 | 15.0 | a、b | 4.91 | 12.0 | d | 3.78 |
尿素 | 467 | 98.29 | 11 | 8.0 | 2.28 | 20.0 | e | 6.80 | 8.0 | a | 2.28 |
肌酐 | 470 | 99.36 | 11 | 12.0 | 3.92 | 20.0 | e | 7.05 | 7.4 | c | 2.12 |
尿酸 | 466 | 99.79 | 11 | 12.0 | 4.90 | 13.0 | e | 5.37 | 10.0 | b | 3.95 |
高密度脂蛋白胆固醇 | 389 | 97.94 | 12 | 30.0 | 4.34 | 30.0 | a | 4.34 | 11.1 | c | 1.08 |
低密度脂蛋白胆固醇 | 387 | 99.48 | 11 | 30.0 | 5.29 | 30.0 | a | 5.29 | 10.0 | d | 1.18 |
载脂蛋白A | 354 | 99.72 | 2 | 30.0 | 5.38 | 30.0 | a | 5.38 | 7.6 | c | 0.76 |
载脂蛋白 B | 354 | 99.44 | 2 | 30.0 | 4.61 | 30.0 | a | 4.61 | 10.0 | d | 0.98 |
糖化血红蛋白 | 338 | 96.75 | 3 | 7.0 | 2.07 | 18.0 | e | 6.89 | 2.2 | c | -0.02 |
钾 | 374 | 100.00 | 11 | 6.0 | 2.56 | 8.0 | e | 3.67 | 4.8 | c | 1.89 |
钠 | 374 | 97.86 | 11 | 4.0 | 2.20 | 5.0 | e | 2.96 | 0.7 | c | -0.29 |
钙 | 255 | 99.61 | 8 | 5.0 | 1.47 | 10.0 | e | 3.80 | 2.3 | c | 0.21 |
磷 | 233 | 99.57 | 8 | 10.0 | 3.22 | 10.0 | a、b | 3.22 | 8.0 | d | 2.42 |
锂 | 9 | 100.00 | 1 | 25.0 | 1.19 | 25.0 | a | 1.19 | 10.0 | d | -0.06 |
葡萄糖 | 463 | 99.57 | 11 | 7.0 | 2.75 | 15.0 | e | 6.76 | 6.5 | c | 2.50 |
碱性磷酸酶 | 447 | 99.78 | 2 | 18.0 | 2.03 | 20.0 | b | 2.34 | 12.0 | d | 1.10 |
乳酸脱氢酶 | 343 | 99.71 | 9 | 11.0 | 2.82 | 18.0 | e | 5.07 | 7.7 | c | 1.76 |
肌酸激酶 | 306 | 100.00 | 8 | 15.0 | 4.50 | 22.6 | c | 7.16 | 12.0 | d | 3.45 |
淀粉酶 | 180 | 100.00 | 8 | 15.0 | 4.81 | 15.0 | a | 4.81 | 10.0 | b、d | 2.96 |
总胆汁酸 | 273 | 97.07 | 2 | 20.0 | 2.07 | 20.0 | a | 2.07 | 10.0 | d | 0.65 |
同型半胱氨酸 | 276 | 98.91 | 1 | 20.0 | 3.15 | 20.0 | a | 3.15 | 10.0 | d | 1.16 |
游离脂肪酸 | 155 | 100.00 | 1 | 20.0 | 3.93 | 20.0 | a | 3.93 | 20.0 | a | 3.93 |
糖化血清白蛋白 | 152 | 98.03 | 2 | 15.0 | 2.46 | 15.0 | a | 2.46 | 2.6 | c | -0.20 |
α氢丁酸脱氢酶 | 71 | 100.00 | 6 | 25.0 | 3.92 | 25.0 | a | 3.92 | 25.0 | a | 3.92 |
项目 | 实验室数/家 | EQA合格率/% | 分组数 | TEaSCCL/ % | σSCCL | TEamax/ % | TEamax 来源 | σmax | TEamin/ % | TEamin 来源 | σmin |
临床血液和体液类 | |||||||||||
白细胞计数 | 750 | 99.20 | 14 | 15.0 | 3.42 | 18.0 | e | 4.27 | 10.0 | d | 2.01 |
红细胞计数 | 750 | 99.20 | 14 | 6.0 | 3.58 | 10.0 | d | 6.52 | 3.9 | c | 2.03 |
血红蛋白 | 750 | 99.47 | 14 | 6.0 | 4.33 | 6.0 | a、e | 4.33 | 3.8 | c | 2.43 |
血细胞比容 | 750 | 98.67 | 14 | 9.0 | 3.81 | 20.0 | d | 9.47 | 3.9 | c | 1.16 |
血小板计数 | 750 | 99.60 | 14 | 20.0 | 4.55 | 25.0 | b、d | 5.89 | 11.3 | c | 2.23 |
平均红细胞体积 | 750 | 98.53 | 13 | 7.0 | 3.45 | 10.0 | d | 5.26 | 1.6 | c | 0.19 |
平均血红蛋白含量 | 750 | 99.20 | 14 | 7.0 | 4.44 | 10.0 | d | 6.70 | 1.1 | c | -0.01 |
平均血红蛋白浓度 | 750 | 98.93 | 13 | 8.0 | 3.33 | 10.0 | d | 4.35 | 1.3 | c | -0.13 |
凝血酶原时间 | 303 | 98.35 | 10 | 15.0 | 3.80 | 20.0 | d | 5.33 | 15.0 | a、b | 3.80 |
凝血酶原时间标准化比值 | 302 | 99.01 | 10 | 15.0 | 2.99 | 15.0 | a、d | 2.99 | 15.0 | a、d | 2.99 |
纤维蛋白原 | 291 | 99.31 | 10 | 20.0 | 3.70 | 25.0 | d | 4.83 | 20.0 | a、b | 3.70 |
抗凝血酶原 | 54 | 92.59 | 3 | 15.0 | 2.08 | 25.0 | d | 4.12 | 15.0 | a | 2.08 |
临床免疫类 | |||||||||||
IgA | 133 | 100.00 | 4 | 25.0 | 5.73 | 25.0 | a | 5.73 | 9.8 | c | 1.77 |
IgG | 133 | 100.00 | 4 | 25.0 | 5.36 | 25.0 | a | 5.36 | 7.3 | c | 1.01 |
IgM | 133 | 100.00 | 4 | 25.0 | 5.04 | 26.0 | e | 5.28 | 15.0 | d | 2.70 |
IgE | 87 | 98.85 | 5 | 25.0 | 5.04 | 25.0 | a | 5.04 | 20.0 | b、d | 3.90 |
C3 | 123 | 100.00 | 3 | 25.0 | 5.67 | 25.0 | a | 5.67 | 7.8 | c | 1.20 |
C4 | 122 | 100.00 | 3 | 25.0 | 4.14 | 25.0 | a | 4.14 | 10.0 | d | 1.13 |
C反应蛋白 | 63 | 100.00 | 16 | 25.0 | 5.07 | 50.7 | c | 10.98 | 20.0 | d、e | 3.93 |
T3 | 232 | 100.00 | 11 | 25.0 | 4.75 | 30.0 | b | 5.85 | 11.6 | c | 1.79 |
总甲状腺素 | 232 | 100.00 | 10 | 20.0 | 4.33 | 24.0 | e | 5.35 | 8.7 | c | 1.44 |
总前列腺特异性抗原 | 206 | 100.00 | 11 | 25.0 | 5.50 | 25.0 | a、e | 5.50 | 8.0 | d | 1.24 |
游离前列腺抗原 | 183 | 98.91 | 10 | 25.0 | 5.60 | 25.0 | a | 5.60 | 15.0 | d | 3.02 |
胰岛素 | 164 | 97.56 | 8 | 25.0 | 4.41 | 35.9 | c | 6.18 | 12.0 | d | 1.01 |
甲胎蛋白 | 240 | 100.00 | 11 | 25.0 | 5.53 | 34.8 | c | 8.06 | 12.0 | d | 2.17 |
项目 | 实验室数/家 | EQA合格率/% | 分组数 | TEaSCCL/ % | σSCCL | TEamax/ % | TEamax 来源 | σmax | TEamin/ % | TEamin 来源 | σmin |
---|---|---|---|---|---|---|---|---|---|---|---|
临床生化类 | |||||||||||
总蛋白 | 461 | 99.57 | 11 | 5.0 | 1.63 | 10.0 | e | 3.98 | 3.5 | c | 0.90 |
白蛋白 | 468 | 99.36 | 2 | 6.0 | 0.95 | 20.0 | e | 4.83 | 3.4 | c | 0.24 |
丙氨酸氨基转移酶 | 472 | 100.00 | 11 | 16.0 | 4.27 | 21.0 | e | 5.84 | 12.0 | d | 3.01 |
天门冬氨酸氨基转移酶 | 461 | 99.78 | 11 | 15.0 | 4.55 | 21.0 | e | 6.68 | 12.0 | d | 3.48 |
γ-谷氨酰转肽酶 | 455 | 99.78 | 11 | 11.0 | 2.94 | 21.0 | e | 6.31 | 11.0 | a | 2.94 |
总胆红素 | 459 | 98.69 | 2 | 15.0 | 2.35 | 22.0 | e | 3.81 | 12.0 | d | 1.72 |
总胆固醇 | 445 | 98.88 | 11 | 9.0 | 3.42 | 13.0 | e | 5.37 | 6.0 | d | 1.96 |
三酰甘油 | 446 | 99.55 | 11 | 14.0 | 2.97 | 27.0 | c | 6.43 | 12.0 | d | 2.43 |
镁 | 160 | 93.75 | 8 | 15.0 | 1.79 | 15.0 | a、b、e | 1.79 | 4.0 | c | -0.10 |
铁 | 115 | 100.00 | 7 | 15.0 | 4.91 | 15.0 | a、b | 4.91 | 12.0 | d | 3.78 |
尿素 | 467 | 98.29 | 11 | 8.0 | 2.28 | 20.0 | e | 6.80 | 8.0 | a | 2.28 |
肌酐 | 470 | 99.36 | 11 | 12.0 | 3.92 | 20.0 | e | 7.05 | 7.4 | c | 2.12 |
尿酸 | 466 | 99.79 | 11 | 12.0 | 4.90 | 13.0 | e | 5.37 | 10.0 | b | 3.95 |
高密度脂蛋白胆固醇 | 389 | 97.94 | 12 | 30.0 | 4.34 | 30.0 | a | 4.34 | 11.1 | c | 1.08 |
低密度脂蛋白胆固醇 | 387 | 99.48 | 11 | 30.0 | 5.29 | 30.0 | a | 5.29 | 10.0 | d | 1.18 |
载脂蛋白A | 354 | 99.72 | 2 | 30.0 | 5.38 | 30.0 | a | 5.38 | 7.6 | c | 0.76 |
载脂蛋白 B | 354 | 99.44 | 2 | 30.0 | 4.61 | 30.0 | a | 4.61 | 10.0 | d | 0.98 |
糖化血红蛋白 | 338 | 96.75 | 3 | 7.0 | 2.07 | 18.0 | e | 6.89 | 2.2 | c | -0.02 |
钾 | 374 | 100.00 | 11 | 6.0 | 2.56 | 8.0 | e | 3.67 | 4.8 | c | 1.89 |
钠 | 374 | 97.86 | 11 | 4.0 | 2.20 | 5.0 | e | 2.96 | 0.7 | c | -0.29 |
钙 | 255 | 99.61 | 8 | 5.0 | 1.47 | 10.0 | e | 3.80 | 2.3 | c | 0.21 |
磷 | 233 | 99.57 | 8 | 10.0 | 3.22 | 10.0 | a、b | 3.22 | 8.0 | d | 2.42 |
锂 | 9 | 100.00 | 1 | 25.0 | 1.19 | 25.0 | a | 1.19 | 10.0 | d | -0.06 |
葡萄糖 | 463 | 99.57 | 11 | 7.0 | 2.75 | 15.0 | e | 6.76 | 6.5 | c | 2.50 |
碱性磷酸酶 | 447 | 99.78 | 2 | 18.0 | 2.03 | 20.0 | b | 2.34 | 12.0 | d | 1.10 |
乳酸脱氢酶 | 343 | 99.71 | 9 | 11.0 | 2.82 | 18.0 | e | 5.07 | 7.7 | c | 1.76 |
肌酸激酶 | 306 | 100.00 | 8 | 15.0 | 4.50 | 22.6 | c | 7.16 | 12.0 | d | 3.45 |
淀粉酶 | 180 | 100.00 | 8 | 15.0 | 4.81 | 15.0 | a | 4.81 | 10.0 | b、d | 2.96 |
总胆汁酸 | 273 | 97.07 | 2 | 20.0 | 2.07 | 20.0 | a | 2.07 | 10.0 | d | 0.65 |
同型半胱氨酸 | 276 | 98.91 | 1 | 20.0 | 3.15 | 20.0 | a | 3.15 | 10.0 | d | 1.16 |
游离脂肪酸 | 155 | 100.00 | 1 | 20.0 | 3.93 | 20.0 | a | 3.93 | 20.0 | a | 3.93 |
糖化血清白蛋白 | 152 | 98.03 | 2 | 15.0 | 2.46 | 15.0 | a | 2.46 | 2.6 | c | -0.20 |
α氢丁酸脱氢酶 | 71 | 100.00 | 6 | 25.0 | 3.92 | 25.0 | a | 3.92 | 25.0 | a | 3.92 |
项目 | 实验室数/家 | EQA合格率/% | 分组数 | TEaSCCL/ % | σSCCL | TEamax/ % | TEamax 来源 | σmax | TEamin/ % | TEamin 来源 | σmin |
临床血液和体液类 | |||||||||||
白细胞计数 | 750 | 99.20 | 14 | 15.0 | 3.42 | 18.0 | e | 4.27 | 10.0 | d | 2.01 |
红细胞计数 | 750 | 99.20 | 14 | 6.0 | 3.58 | 10.0 | d | 6.52 | 3.9 | c | 2.03 |
血红蛋白 | 750 | 99.47 | 14 | 6.0 | 4.33 | 6.0 | a、e | 4.33 | 3.8 | c | 2.43 |
血细胞比容 | 750 | 98.67 | 14 | 9.0 | 3.81 | 20.0 | d | 9.47 | 3.9 | c | 1.16 |
血小板计数 | 750 | 99.60 | 14 | 20.0 | 4.55 | 25.0 | b、d | 5.89 | 11.3 | c | 2.23 |
平均红细胞体积 | 750 | 98.53 | 13 | 7.0 | 3.45 | 10.0 | d | 5.26 | 1.6 | c | 0.19 |
平均血红蛋白含量 | 750 | 99.20 | 14 | 7.0 | 4.44 | 10.0 | d | 6.70 | 1.1 | c | -0.01 |
平均血红蛋白浓度 | 750 | 98.93 | 13 | 8.0 | 3.33 | 10.0 | d | 4.35 | 1.3 | c | -0.13 |
凝血酶原时间 | 303 | 98.35 | 10 | 15.0 | 3.80 | 20.0 | d | 5.33 | 15.0 | a、b | 3.80 |
凝血酶原时间标准化比值 | 302 | 99.01 | 10 | 15.0 | 2.99 | 15.0 | a、d | 2.99 | 15.0 | a、d | 2.99 |
纤维蛋白原 | 291 | 99.31 | 10 | 20.0 | 3.70 | 25.0 | d | 4.83 | 20.0 | a、b | 3.70 |
抗凝血酶原 | 54 | 92.59 | 3 | 15.0 | 2.08 | 25.0 | d | 4.12 | 15.0 | a | 2.08 |
临床免疫类 | |||||||||||
IgA | 133 | 100.00 | 4 | 25.0 | 5.73 | 25.0 | a | 5.73 | 9.8 | c | 1.77 |
IgG | 133 | 100.00 | 4 | 25.0 | 5.36 | 25.0 | a | 5.36 | 7.3 | c | 1.01 |
IgM | 133 | 100.00 | 4 | 25.0 | 5.04 | 26.0 | e | 5.28 | 15.0 | d | 2.70 |
IgE | 87 | 98.85 | 5 | 25.0 | 5.04 | 25.0 | a | 5.04 | 20.0 | b、d | 3.90 |
C3 | 123 | 100.00 | 3 | 25.0 | 5.67 | 25.0 | a | 5.67 | 7.8 | c | 1.20 |
C4 | 122 | 100.00 | 3 | 25.0 | 4.14 | 25.0 | a | 4.14 | 10.0 | d | 1.13 |
C反应蛋白 | 63 | 100.00 | 16 | 25.0 | 5.07 | 50.7 | c | 10.98 | 20.0 | d、e | 3.93 |
T3 | 232 | 100.00 | 11 | 25.0 | 4.75 | 30.0 | b | 5.85 | 11.6 | c | 1.79 |
总甲状腺素 | 232 | 100.00 | 10 | 20.0 | 4.33 | 24.0 | e | 5.35 | 8.7 | c | 1.44 |
总前列腺特异性抗原 | 206 | 100.00 | 11 | 25.0 | 5.50 | 25.0 | a、e | 5.50 | 8.0 | d | 1.24 |
游离前列腺抗原 | 183 | 98.91 | 10 | 25.0 | 5.60 | 25.0 | a | 5.60 | 15.0 | d | 3.02 |
胰岛素 | 164 | 97.56 | 8 | 25.0 | 4.41 | 35.9 | c | 6.18 | 12.0 | d | 1.01 |
甲胎蛋白 | 240 | 100.00 | 11 | 25.0 | 5.53 | 34.8 | c | 8.06 | 12.0 | d | 2.17 |
1 | 上海市卫生健康委员会. 关于印发《上海市进一步规范医疗行为促进合理医疗检查的实施方案》的通知. [EB/OL]. (2021-06-25)[2021-11-10]. https://wsjkw.sh.gov.cn/yzgl3/20210625/afabb488bb834ae4b5ea64464b57a119.html. |
2 | 中国合格评定国家认可委员会. CNAS-GL003 能力验证样品均匀性和稳定性评价指南[S]. 北京: 中国合格评定国家认可委员会, 2018. |
3 | WESTGARD S, BAYAT H, WESTGARD J O. Analytical sigma metrics:a review of six sigma implementation tools for medical laboratories[J]. Biochem Med(Zagreb), 2018, 28(2):020502. |
4 | Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods[S]. EP05-A2,CLSI, 2004. |
5 | 王青, 宋颖, 许蕾, 等. 上海地区全血细胞计数结果可比性和一致性调查[J]. 检验医学, 2017, 32(12):1159-1164. |
6 |
JU Y, CAO Z T, LI Q, et al. Recommendations for proficiency testing criteria for hemoglobin A1c based on the Shanghai Center for Clinical Laboratory's study[J]. Clin Chem Lab Med, 2021, 59(10):1728-1734.
DOI URL |
7 | JONES G R D, ALBAREDE S, KESSELER D, et al. Analytical performance specifications for external quality assessment-definitions and descriptions[J]. Clin Chem Lab Med, 2017, 55(7):949-955. |
8 |
SHARMA L K, DATTA R R, SHARMA N. Sigma metric evaluation of drugs in a clinical laboratory:importance of choosing appropriate total allowable error and a troubleshooting roadmap[J]. J Lab Physicians, 2021, 13(1):44-49.
DOI URL |
9 |
LI C, WANG Y, LU H, et al. Study of total error specifications of lymphocyte subsets enumeration using China National EQAS data and Biological Variation Data Critical Appraisal Checklist(BIVAC)-compliant publications[J]. Clin Chem Lab Med, 2020, 59(1):179-186.
DOI URL |
10 |
AARSAND A K, RØRAAS T, FERNANDEZ-CALLE P, et al. The biological variation data critical appraisal checklist:a standard for evaluating studies on biological variation[J]. Clin Chem, 2018, 64(3):501-514.
DOI URL |
11 |
BAIS R. EQA from an Australian perspective[J]. Clin Biochem Rev, 2007, 28(4):175-178.
PMID |
12 | JONES G R, SIKARIS K, GILL J. 'Allowable limits of performance' for external quality assurance programs-an approach to application of the Stockholm criteria by the RCPA Quality Assurance Programs[J]. Clin Biochem Rev, 2012, 33(4):133-139. |
13 | German Medical Association on Quality Assurance in Medical Laboratory Examinations(Rili-BAEK). Revision of the“Guideline of the German Medical Association on Quality Assurance in Medical Laboratory Examinations-Rili-BAEK”(unauthorized translation)[J]. Lab Med, 2015, 39(1):26-69. |
14 | 中华人民共和国卫生部. WS/T 403—2012 临床生物化学检验常规项目分析质量指标[S]. 2012. |
15 | 中华人民共和国卫生部. WS/T 406—2012 临床血液学检验常规项目分析质量要求[S]. 2012. |
[1] | LIU Xiaowen, SHAO Wenqi, ZHU Jing, YANG Jing, ZHANG Chunyan, PAN Baishen, WANG Beili, GUO Wei. Establishment of reference interval of serum ferritin in adults in Shanghai by indirect method [J]. Laboratory Medicine, 2024, 39(6): 524-529. |
[2] | WANG Zhengquan, WU Zhengmu, LI Wen. Long-term biological variation of serum sex hormones during female follicular phase in Shanghai [J]. Laboratory Medicine, 2024, 39(3): 282-288. |
[3] | ZHAO Qiang, XU Xiuwen, HAN Jiaojiao, SONG Ying, MIAO Yingbo, ZHU Peichao, ZHOU Wei, LIN Shiyang, TONG Lanfei, CHE Yiming, JIN Lei, XU Chong. Effect of different preservation methods on stability of samples in external quality assessment of paroxysmal nocturnal hemoglobinuria by flow cytometry [J]. Laboratory Medicine, 2024, 39(11): 1048-1052. |
[4] | JIANG Haoqin, XU Qianqian, XU Liming, GUAN Ming. Homogenization management and practice of clinical blood and body fluid determinations [J]. Laboratory Medicine, 2024, 39(1): 95-99. |
[5] | YANG Xue, ZHU Jun, JIANG Lingli, WANG Qing, HU Xiaobo. Evaluation on the consistency of blind sample test results of 9 SARS-CoV-2 nucleic acid determination kits in Shanghai,China [J]. Laboratory Medicine, 2023, 38(8): 776-780. |
[6] | ZHANG Weimin, LI Ting, ZHANG Chen, XIE Nan, ZHAO Fei, WU Xia, MENG Qinghao, LI Min, GAO Xuan, YANG Sijie. Role of Youden plot in external quality assessment of sperm concentration [J]. Laboratory Medicine, 2023, 38(2): 167-171. |
[7] | DENG Shanying, PEI Yuqing, ZHANG Chunying, XIE Heng, MENG Qiang, MA Ying. Analysis of external quality assessment of parasite morphology from 2013 to 2020 in West China Hospital of Sichuan University [J]. Laboratory Medicine, 2022, 37(2): 188-193. |
[8] | CHEN Hongwei, GUO Haitao, HOU Yanqiang. New development of regional medical laboratory centers in post-pandemic era [J]. Laboratory Medicine, 2022, 37(12): 1118-1121. |
[9] | ZHANG Pengyin, QUAN Jing, WANG Xueliang, XIAO Yanqun, BAO Yun. External quality assessment of irinotecan-related metabolism genotyping in Shanghai [J]. Laboratory Medicine, 2021, 36(8): 875-879. |
[10] | CHEN Rong, ZHANG Minmin, XIA Qihang, QIAN Chengkai, CUI Lin, LIU Xuejie, XU Rong, WANG Qingzhong, GE Ping, HUANG Weigang, WANG Jinghua. External quality assessment of fungal culture identification and in vitro drug sensitivity test in Shanghai [J]. Laboratory Medicine, 2021, 36(4): 441-443. |
[11] | LI Qing, JU Yi, TANG Liping, JIN Zhonggan, SUN Hewei. Application of candidate reference method of apolipoprotein A1 and apolipoprotein B in external quality assessment [J]. Laboratory Medicine, 2021, 36(3): 259-262. |
[12] | FANG Huiling, GE Danhong, ZHU Yuqing, ZHU Lingfeng, ZHAO Xiaojun, CHEN Ziqi, WANG Zimeng. Analysis on the external quality assessment results for 25-hydroxyvitamin D of Shanghai from 2015 to 2019 [J]. Laboratory Medicine, 2021, 36(2): 219-224. |
[13] | LIU Zhangling, LI Juan, PU Ran, TANG Rongrui. Application of PDCA cycle in promoting mutual recognition of biochemical item determination results [J]. Laboratory Medicine, 2020, 35(9): 943-945. |
[14] | TANG Lin, ZHANG Xiaojing, TANG Zhenhua. Investigation of gestational anemia in Shanghai,2016 [J]. Laboratory Medicine, 2020, 35(2): 116-119. |
[15] | KANG Fengfeng, SHAN Zhiming, SONG Chao, XIA Xiaohua, CHEN Qian, LI Weixing. Comparability of glycated hemoglobin determination results with different determination systems using sigma metrics and robust algorithm [J]. Laboratory Medicine, 2020, 35(2): 168-172. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||